Understanding how protein pathways affect age-related brain diseases
Mechanisms of neurodegenerative diseases: intersections with ubiquitin pathways
This study is looking at how certain proteins that help keep our cells healthy can go wrong in diseases like Alzheimer's and Parkinson's, with the hope of finding new ways to treat these conditions and improve patients' lives.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11083079 on NIH RePORTER |
What this research studies
This research investigates the role of proteins involved in the ubiquitin pathways, which are crucial for maintaining cellular health, particularly in the context of age-related neurodegenerative diseases. By examining how these proteins aggregate and malfunction in diseases like Alzheimer's and Parkinson's, the research aims to uncover new therapeutic targets. The study employs a variety of innovative tools and models to explore the mechanisms behind these diseases, focusing on how disruptions in ubiquitin signaling contribute to neurodegeneration. Patients may benefit from insights that could lead to novel treatments for these debilitating conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include older adults experiencing symptoms of neurodegenerative diseases or those at risk due to genetic factors.
Not a fit: Patients with neurodegenerative diseases unrelated to age or those in very early stages of disease may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that slow down or prevent the progression of age-related neurodegenerative diseases.
How similar studies have performed: Previous research has shown promising results in targeting ubiquitin pathways for neurodegenerative diseases, indicating a potential for success in this approach.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Paulson, Henry L — University of Michigan at Ann Arbor
- Study coordinator: Paulson, Henry L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.